Although, either silencing of DNMT1 or inhibition of HDAC1 & HDAC2 were able to reduce cell migration even after 24 h, both knockdown of DNMT1 and TSA treatment synergistically inhibited migration of MDA-MB-231 breast cancer cells significantly higher (Fig. 7B,C). The gene discussed is HDAC2; the disease is breast cancer.